Dengue can develop into life-threatening complications known as severe dengue. Yet, there is still no specific treatment available.
Together with our partners, we're working to change this.
📣 Share this post to raise awareness this #WorldDengueDay#OneWorldAgainstDengue
💊 Today, hope is growing for people like Mbo. The Democratic Republic of the Congo (DRC) has approved acoziborole, a single-dose oral treatment for sleeping sickness!
@WHO#1Dose1Cure#StandWithScience
🦟#Dengue is an emerging health threat for 🇪🇺.
Climate change, urbanisation and mobility are creating conditions for dengue to spread beyond traditionally affected regions.
#EU can learn from the experience of Asia and Latin America to strengthen #preparedness before cases rise.
Before 2016, only a few scientists were working on #mycetoma. Now, 200 scientists spread over 36 countries are researching to bring an end to the debilitating disease, thanks to partnerships with organizations like @dndi. Learn more about the journey -> globalhealthnow.org/2026-05/…
As global health budgets shrink, three Geneva-based non-profit R&D groups —
@DNDi, @gardp_amr & @MedsforMalaria — are joining forces to accelerate lifesaving medicines for malaria, neglected diseases and antimicrobial resistance.
✍️@kerrycullinan11
For years, #mycetoma left Banchayehu from Ethiopia with a heavily swollen foot, unable to wear shoes or care for her 3 kids. After finding treatment at Boru Meda Hospital, she's reclaimed her life. Her journey reminds us why we advocate for early diagnosis & health equity.
⚽ Developing a treatment isn’t a solo run. It’s a team effort.
As the world gets ready to kick off the #Football World Cup tomorrow, we’re spotlighting a different kind of squad 👉the one it takes to develop life-saving medicines for people with neglected diseases. #FIFAWorldCup
🦠 How do you design a medicine for a virus that doesn’t even exist yet?
In this video, Fanny Escudié, our Senior Discovery Project Manager, breaks down how scientists are preparing for future pandemics with broad-spectrum antivirals.
We join forces with @gardp_amr & @MedsforMalaria to accelerate drug development for patients in greatest need!
@Emma_Hannay, Chief Strategy Officer at MMV, explains why this collaboration is especially important in this changing global health ecosystem.
👉 dndi.org/press-releases/2026…
In 2016, #mycetoma was recognized among the #NTDs & thru partnerships and patient-centered research, @DNDi is working to make treatments safer, more effective, and accessible.
Continued research, innovation, and care are vital to end this disease.
#MycetomaAt10#BeatNTDs
Last week we participated at a high-level #WHA79 meeting reaffirming shared political commitment to strengthen cross-border collaboration and accelerate elimination of #malaria and neglected tropical diseases (#NTDs). Read @who's press release here: who.int/news/item/25-05-2026…
#Mycetoma in Ethiopia’s Afar region is often detected late, leading to disability & limb loss. In this study, nearly 90% of patients presented after 12 months of symptoms and 13% required amputation. @PLOSNTDsjournals.plos.org/plosntds/a…
Happening in 2 Days!
Join IMPAACT4HIV's upcoming cross-learning webinar exploring how Community-Led Monitoring (CLM) is helping communities identify barriers, strengthen clinic-community collaboration, and use data to drive meaningful change for Advanced HIV Disease (AHD) responses across Africa.
Featuring experiences and lessons from the DRC, Guinea (GRC), and Mozambique.
🔗Register here: bit.ly/4tQrKb9
Finding new treatments for #Chagas disease is urgent. This study screened over 2,400 compounds and identified promising candidates, using approaches like cell painting to understand how they act against T. cruzi.
sciencedirect.com/science/ar…
A powerful tribute from @ProfAHFahal, honors Dr @bornanyaoke (@DNDi ), the 2025 Mycetoma Ambassador. Her extraordinary leadership kept critical care alive for neglected patients during the darkest chapters of the Sudan conflict. 🧵👇
mycetoma.edu.sd/?p=7395
We welcome the new Global Action Plan on #AMR, incl. commitments to strengthen R&D & ensure equitable access to treatments. AMR should be integrated into global health reform discussions. #WHA79
Read full statement: dndi.org/statements/2026/dnd…
This #InternationalClinicalTrialsDay, the @MycetomaRC celebrates a global health milestone: leading the world’s first randomised clinical trial for #mycetoma, bringing hope to neglected communities! 🌟
Deep thanks to @DNDi, @Eisai, & others for their steadfast partnership!
On #InternationalClinicalTrialsDay, we celebrate the resilience of the @MycetomaRC, pioneers of the world’s first randomized #mycetoma clinical trial. Despite conflict and destruction @ProfAHFahal and his team continue to rebuild with extraordinary grit and determination. #NTDs
We welcome Global Health Architecture reform discussions & stress biomedical innovation must be core. Market forces alone won’t deliver public‑health R&D. Reform must boost public‑interest models & ensure innovation is governed & financed for impact&equity dndi.org/statements/2026/dnd…